BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, March 29, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
June 2, 2010
View Archived Issues
GSK-256066 safe and well tolerated in patients with COPD
Read More
Auto TAG vaccine shows clinical benefit in advanced cancer
Read More
Ad3-hTERT-E1A shows favorable clinical safety in solid tumors
Read More
E. coli DH5 alpha-delivered sTRAIL shows promise as solid tumor therapy
Read More
Phase IIb safety and efficacy data presented on MP-376 in cystic fibrosis
Read More
Phase II data suggest talactoferrin reduces mortality in severe sepsis
Read More
High plasma endostatin predicts worse functional outcome in t-PA-treated stroke patients
Read More
NovaBay Pharmaceuticals claims new antimicrobial agents
Read More
New CXCR7 modulators described by ChemoCentryx
Read More
Auspex Pharmaceuticals claims new glucocorticoid receptor modulators
Read More
Bayer Schering Pharma discloses new HIF inhibitors
Read More
Genzyme discloses achievements of first quarter 2010
Read More
Orexo and OMJ join to develop therapeutics for respiratory diseases
Read More
EMA considers postapproval commitment fulfilled for Ceplene/IL-2 in AML
Read More
Novel FAAH inhibitors presented by sanofi-aventis
Read More
Onyx begins phase I trial of oral proteasome inhibitor ONX-0912
Read More
Phase II trial of BCX-4208 with or without allopurinol initiated in gout
Read More
AstraZeneca receives FDA complete response letters on Axanum and Nexium
Read More
CrystalGenomics' phase I trial of CG-200745 approved in Korea
Read More
FDA accepts Qnexa NDA for obesity for review
Read More
Genfit receives approval for two IT-Diab trials in France
Read More
HUYA and BUCM to codevelop therapeutics from traditional Chinese medicine
Read More
CF-102 decreases HCV load in patient with liver cancer
Read More
Covidien to acquire ev3
Read More
FDA grants priority review to eribulin mesilate NDA for breast cancer
Read More
Bioheart plans cell therapy program in CHF and PAD in Middle East
Read More
Artec reports improvements of Tubercin for HIV/AIDS
Read More